JP2025510594A5 - - Google Patents
Info
- Publication number
- JP2025510594A5 JP2025510594A5 JP2024553845A JP2024553845A JP2025510594A5 JP 2025510594 A5 JP2025510594 A5 JP 2025510594A5 JP 2024553845 A JP2024553845 A JP 2024553845A JP 2024553845 A JP2024553845 A JP 2024553845A JP 2025510594 A5 JP2025510594 A5 JP 2025510594A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding fragment
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263320646P | 2022-03-16 | 2022-03-16 | |
| US63/320,646 | 2022-03-16 | ||
| PCT/US2023/064478 WO2023178208A2 (en) | 2022-03-16 | 2023-03-15 | Btn1a1 binding proteins and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510594A JP2025510594A (ja) | 2025-04-15 |
| JP2025510594A5 true JP2025510594A5 (enExample) | 2026-03-31 |
Family
ID=88024430
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024553845A Pending JP2025510594A (ja) | 2022-03-16 | 2023-03-15 | Ｂｔｎ１ａ１結合タンパク質及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250189530A1 (enExample) |
| EP (1) | EP4493594A2 (enExample) |
| JP (1) | JP2025510594A (enExample) |
| KR (1) | KR20240154675A (enExample) |
| CN (1) | CN119213031A (enExample) |
| AU (1) | AU2023236798A1 (enExample) |
| CA (1) | CA3245343A1 (enExample) |
| WO (1) | WO2023178208A2 (enExample) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109071636A (zh) * | 2016-03-29 | 2018-12-21 | 斯特库比股份有限公司 | 用于选择特异性结合糖基化免疫检查点蛋白的抗体的方法 |
| GB201909393D0 (en) * | 2019-06-28 | 2019-08-14 | Gen2 Neuroscience Ltd | Tau epitope and binding molecules |
| KR20220118527A (ko) * | 2019-12-23 | 2022-08-25 | 제넨테크, 인크. | 아포지질단백질 l1-특이적 항체 및 이용 방법 |
-
2023
- 2023-03-15 KR KR1020247034045A patent/KR20240154675A/ko active Pending
- 2023-03-15 US US18/847,179 patent/US20250189530A1/en active Pending
- 2023-03-15 CA CA3245343A patent/CA3245343A1/en active Pending
- 2023-03-15 JP JP2024553845A patent/JP2025510594A/ja active Pending
- 2023-03-15 CN CN202380040960.8A patent/CN119213031A/zh active Pending
- 2023-03-15 EP EP23771653.5A patent/EP4493594A2/en active Pending
- 2023-03-15 AU AU2023236798A patent/AU2023236798A1/en active Pending
- 2023-03-15 WO PCT/US2023/064478 patent/WO2023178208A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021516051A5 (enExample) | ||
| CA3184008A1 (en) | Anti-cldn18.2 antibodies and diagnostic uses thereof | |
| JP2023527937A5 (enExample) | ||
| JP7828500B2 (ja) | ホスホ－タウ抗体および使用の方法 | |
| CN113214393A (zh) | Il-6抗体或其抗原结合片段及包含其的检测试剂盒 | |
| CN111133001A (zh) | 用于分析目的的多价单或双特异性重组抗体 | |
| WO2021182555A1 (ja) | アルドステロン検出用抗体及びアルドステロンの免疫測定方法 | |
| CN117683121B (zh) | 抗水痘-带状疱疹病毒抗体及其应用 | |
| US11009507B2 (en) | Methods and diagnostics for cancer detection and treatment monitoring | |
| CN116802212A (zh) | 胃泌酸调节素结合分子及其用途 | |
| WO2018135653A1 (ja) | 抗ｅｐｈａ２抗体及びこれを用いたｅｐｈａ２の免疫学的検出 | |
| JP2025510594A5 (enExample) | ||
| CN117285637B (zh) | 一种抗独特型抗体及其应用 | |
| JP2020515286A5 (enExample) | ||
| CN116003615B (zh) | 一种抗卡利普多的单克隆抗体及其应用 | |
| JP2021515210A (ja) | 免疫療法のためのバイオマーカーとしてのプロガストリン | |
| KR102314451B1 (ko) | 단백질 키나아제 a의 촉매 서브 유닛 알파에 특이적으로 결합하는 단일클론항체 및 이를 활용한 암 진단 용도 | |
| CN114761803B (zh) | 使用抗bag2抗体诊断癌症的方法 | |
| US12319749B2 (en) | Antibody and functional fragment thereof | |
| KR20230124280A (ko) | 메르스 코로나 바이러스의 뉴클레오캡시드 단백질에 특이적인 진단용 항체 및 이의 용도 | |
| CN120424221B (zh) | 靶向德曲妥珠单抗的抗体及其用途 | |
| CN108727493B (zh) | 抗Stathmin单克隆抗体及其用途 | |
| FI131968B1 (en) | ANTIBODY BINDINGS AS CANCER BIOMARKERS | |
| EP4403581A1 (en) | Anti-ck2 alpha antibody or fragment thereof | |
| KR20200002190A (ko) | 항 스핑고신-1-포스페이트 작용제, 이의 생산 방법, 및 이의 용도 |